Xilio Therapeutics (XLO) announced three wholly-owned preclinical programs for masked T cell engagers targeting prostate-specific membrane ...

AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to ...

Neonates and young infants exposed to extracorporeal circulation during extracorporeal membrane oxygenation ... to investigate the hypothesis that epithelial apoptosis is an early event that ...